2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
JACC: Basic to Translational Science
Publisher's siteResearch at a glance
Top areas of exploration
- Clopidogrel , 1 publications
- Platelet Aggregation Inhibitors , 1 publications
- Cytochrome P-450 CYP2C19 , 1 publications
- Percutaneous Coronary Intervention , 1 publications
Research activity
My publications
Filter publications
48 publications
2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Journal of the American Heart Association
Publisher's site2024
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score
Journal of the American College of Cardiology
PubMed • Publisher's site2024
P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study
JACC: Cardiovascular Interventions
Publisher's site2024
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study
Thrombosis and Haemostasis
Publisher's site